Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × talazoparib × Other solid neoplasm × Clear all

Phase

Phase 1 8 Phase 1/2 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 18 Genitourinary 10 Tumor-Agnostic 6 Gynecologic 6 Thoracic 4 Gastrointestinal 3 CNS 2 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Lymphoid 1 Endocrine 1

Conditions

Mesothelioma, Malignant 1

Interventions

Cisplatin 42 Pemetrexed 31 Carboplatin 28 Nivolumab 21 pembrolizumab 19 Gemcitabine 19 atezolizumab 13 Etoposide 13 Injections 12 Ipilimumab 11 Cyclophosphamide 11 Radiotherapy 10 Oxaliplatin 10 Filgrastim 10 Docetaxel 10 Bevacizumab 10 tislelizumab 9 Vincristine 9 Specimen Handling 9 durvalumab 8 Paclitaxel 8 Capecitabine 8 tremelimumab 7 toripalimab 7 lenvatinib 7 Everolimus 7 spartalizumab 6 olaparib 6 niraparib 6 Vinorelbine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04462809 2020-07-09

TALAMESO

Hospices Civils de Lyon

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡